Headlines:
Search for Healthcare Articles by

Generics-Regulatory Impact on Marketing


< Previous   Page 3 of 21   Next >
Search returned 203 items.
sort by:   Title | Author | Publication | Date

FDA Proposes New, Tougher Procedures for Membership on Advisory Committees

...more stringent approach for considering potential conflicts of interest for its advisory committee members and for recommending eligibility ...
http://www.fda.gov/bbs/topics/NEWS/2007/NEW01591.html

FDA probing safety of children's cold medicines

Over-the-counter remedies haven't been tested enough, newspaper reports
http://www.msnbc.msn.com/id/17417416/

MEDICAID CUTS WOULD CHILL GENERIC DISPENSING

Instead of encouraging community pharmacists to help control health costs by dispensing lower-priced generic drugs, the Bush Administration's new reimbursement plan for Medicaid pharmacies will do just the opposite...
http://www.pharmacytimes.com/Article.cfm?Menu=1&ID=4398

STATES PRESSURE FDA FOR GENERIC INSULIN

Mississippi Gov Haley Barbour is leading a group of officials from 11 states in a drive to secure marketing approval for a cost-saving generic version of insulin
http://www.pharmacytimes.com/Article.cfm?Menu=1&ID=4403

SUPREME COURT HANDS VICTORY TO GENERICS

...the Supreme Court struck down a key strategy used by branded pharmaceutical manufacturers to delay competition from lower-cost generics...
http://www.pharmacytimes.com/Article.cfm?Menu=1&ID=4396

Medicare Part D sees flurry of late changes

According to a recent survey from the Kaiser Family Foundation and the Harvard School of Public Health, only...
http://www.drugtopics.com/drugtopics/article/articleDetail.jsp?id=398008

GENERIC WARFARIN A SAFE SUBSTITUTE

A new analysis suggests that substitution of generic warfarin for brand-name warfarin (Coumadin, Bristol-Myers Squibb) has no appreciable effect...
http://www.pharmacytimes.com/Article.cfm?Menu=1&ID=4288

FDA Proposes Labeling Changes to Over-the-Counter Pain Relievers

...regarding the potential for stomach bleeding and liver damage and when to consult a doctor...
http://www.fda.gov/bbs/topics/NEWS/2006/NEW01533.html

DEA proposes easing restrictions on Schedule II drugs

The policy statement reiterates DEA's commitment to striking the proper balance
http://www.drugtopics.com/drugtopics/article/articleDetail.jsp?id=379883

Pharmacies prepare for fraud and abuse audits

clear polices to avoid being investigated or prosecuted for fraud and abuse related to Medicare...
http://www.drugtopics.com/drugtopics/article/articleDetail.jsp?id=376032
< Previous   Page 3 of 21   Next >
Search returned 203 items.
Sponsored Links
Reach these Drug Developers
Via Email or Mail List Rentals
www.biotechmedia.com
Medical Marketing & Media is a monthly
to 14,000 healthcare marketing executives
www.medicalmarketingandmedia.com
Smart strategic thinking and
innovative creative execution
www.adwise.com
Place your ad in this
Must-Read Pharma Mag
www.biotechmedia.com
Over 8,000,000 Mail and
Email addresses available
www.biotechmedia.com